CARL Finance Successfully Advises on the Sale of PAPmed GmbH to Arsipa/Warburg Pincus

About PAPmed:

PAPmed GmbH was founded in Berlin in 2012 and specializes in occupational health services. With locations in Berlin, Rostock, and Weißenfels, the company offers tailored solutions in health protection and occupational safety for businesses across various industries. PAPmed enjoys an excellent reputation for its customized services and sustainable health strategies.

Role of CARL:

CARL acted as the exclusive advisor on the seller's side, leading a structured and goal-oriented sales process. With extensive expertise in the healthcare sector and a deep understanding of the market, CARL was able to optimally position PAPmed in the investor market through careful analysis and targeted preparation. By developing a clear equity story, CARL succeeded in generating broad international interest. Thanks to its specialized M&A advisory competence, CARL negotiated an outstanding outcome for all parties involved.

Transaction Objective and Outcome:

The objective of the transaction was to find a buyer who values PAPmed's existing market position in the region while ensuring a sustainable succession solution.

With Arsipa, a portfolio company of Warburg Pincus, a strategic partner was identified who possesses both the necessary financial strength and a clear vision for the further development of the company. Arsipa will benefit from PAPmed's established market presence and create additional value opportunities for the company's customers. The current management team, consisting of Dr. Michael Wendorf and Dr. Michael Schmitz-Rode, will continue to lead the company into its next phase of growth.

Outlook:

With the successful completion of this transaction, CARL Finance strengthens its position as a leading advisor in the German mid-market, particularly in the healthcare sector. CARL looks forward to supporting future successful transactions and creating added value for its clients.